There is more good news on the vaccine front with a second company announcing preliminary results.
Drugmaker Moderna says clinical trial data found its vaccine to be 94.5% effective.
There is more good news on the vaccine front with a second company announcing preliminary results.
Drugmaker Moderna says clinical trial data found its vaccine to be 94.5% effective.
[NFA] Moderna will apply for U.S. and European emergency-use authorization for its COVID-19 vaccine on Monday after full results..
AstraZeneca said that late-stage trials show its COVID-19 vaccine is up to 90-percent effective. Dr. Mallika Marshall reports.